About the journal
JAMA Oncology is a journal published by American Medical Association in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Medical Association
- ISSN
- 2374-2445 · 2374-2437
- Country
- United States
- Access
- Not open access / not declared
- Official website
- https://jamanetwork.com/journals/jamaoncology
Index listings
- MEDLINE · 2015-01-01
- PUBMED · 2016-05-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
4827
Last recorded publication year
2026
h-index
245
i10-index
1985
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 92%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
Identity & continuity3
- Alternate titles
- Journal of the American Medical Association oncologyJAMA oncol
- Source type
- journal
- NLM unique ID (PubMed)
- 101652861
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
Show all subjects (50)
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Cancer survivorship and care
- Cancer survivorship and care
- Lung Cancer Research Studies
- Palliative Care and End-of-Life Issues
- Lung Cancer Research Studies
- Palliative Care and End-of-Life Issues
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- Cancer Risks and Factors
- Cancer Risks and Factors
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- COVID-19 and healthcare impacts
- COVID-19 and healthcare impacts
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ